European Organisation For Research And Treatment Of Cancer - Eortc
Clinical trials sponsored by European Organisation For Research And Treatment Of Cancer - Eortc, explained in plain language.
-
New combo therapy aims to stop brain metastases in lung cancer patients
Disease control Not yet recruitingThis study tests whether giving radiation to all brain tumors first, followed by a new immunotherapy drug (ivonescimab) plus chemotherapy, works better than starting with the drug and chemo alone. About 158 adults with non-small cell lung cancer that has spread to the brain but w…
Phase: PHASE2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for AML patients: targeted combo challenges standard chemo
Disease control Not yet recruitingThis study compares a new three-drug combination (gilteritinib, azacitidine, and venetoclax) to standard intensive chemotherapy for adults newly diagnosed with a specific genetic subtype of acute myeloid leukemia (FLT3-ITD). About 230 participants aged 18 to 75 will be randomly a…
Phase: PHASE2, PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated May 14, 2026 12:05 UTC